[Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease]

Zhonghua Gan Zang Bing Za Zhi. 2014 May;22(5):374-9. doi: 10.3760/cma.j.issn.1007-3418.2014.05.011.
[Article in Chinese]

Abstract

Objective: To investigate the association between two polymorphisms of the APOC3 gene (T-455C and C-482T) and hereditary risk of non-alcoholic fatty liver disease (NAFLD).

Methods: A total of 287 patients with NAFLD and 310 control subjects were genotyped by PCR and direct sequencing. Serum lipid profiles were also detected by standard biochemical

Methods: One-hundred-and-eighty of the study participants were used to measure the APOC3 content by enzyme-linked immunosorbent assay. Inter-group differences and associations were assessed statistically using Chi square and t tests and logistic and linear regression analyses.

Results: The frequencies of neither the genotypes or alleles were significantly different between the NAFLD cases and the controls. Compared with the most common genotypes-455TT or-482CC, none of the variants showed a significant increase in risk of NAFLD or for the clinical and biochemical parameters. The adjusted odds ratios (with 95% confidence intervals) of NAFLD were 1.25 (0.79-1.96) and 1.20 (0.76-1.89) for carriers of the APOC3-455C and-482 T variants respectively (P more than 0.05).

Conclusion: The T-455C and C-482T polymorphisms of the APOC3 gene are not associated with risk of NAFLD, pathogenic changes in lipid profiles, or insulin resistance in Han Chinese.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Apolipoprotein C-III / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Insulin Resistance
  • Lipids / blood
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / genetics*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic*
  • Young Adult

Substances

  • Apolipoprotein C-III
  • Lipids